Consumer Access to Prescription Drugs Act of 1995

Consumer Access to Prescription Drugs Act of 1995 - Regulates the patent expiration date regarding new drug and new animal drug applications submitted before June 8, 1995 (or submitted after that date but with substantial investment before that date). Declares that the remedies of certain patent provisions shall not apply to acts that were commenced (or that had substantial investment) before that date and that became infringing by reason of specified provisions of the Uruguay Round Agreements Act. Restricts the circumstances in which equitable remuneration may be awarded. Sets forth what constitutes: (1) acts commenced prior to that date; and (2) substantial investment. Specifies the application approval and judicial circumstances to which this Act applies.